Harte Hanks (HHS) Current Deferred Revenue (2010 - 2026)

Harte Hanks (HHS) has 17 years of Current Deferred Revenue data on file, last reported at $2.6 million in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $2.6 million, up 3.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 3.63% YoY), and the FY2025 annual result was $813000.0, down 48.84% from the prior year.
• Current Deferred Revenue improved to $2.6 million in Q1 2026 per HHS's latest filing, from $813000.0 in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $7.0 million in Q3 2022 and troughed at $813000.0 in Q4 2025.
• A 5-year average of $3.9 million and a median of $3.5 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue soared 41.51% in 2022, then sank 50.27% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $4.6 million in 2022, then tumbled by 30.39% to $3.2 million in 2023, then slumped by 50.27% to $1.6 million in 2024, then slumped by 48.84% to $813000.0 in 2025, then soared by 216.36% to $2.6 million in 2026.
• Business Quant data shows HHS's Current Deferred Revenue at $2.6 million in Q1 2026, $813000.0 in Q4 2025, and $2.5 million in Q3 2025.